Sarissa Capital Management as of March 31, 2021
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 14 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 17.6 | $183M | 16M | 11.18 | |
| Biogen Idec (BIIB) | 17.2 | $180M | 643k | 279.75 | |
| Gilead Sciences (GILD) | 16.7 | $174M | 2.7M | 64.63 | |
| Alkermes SHS (ALKS) | 14.2 | $149M | 8.0M | 18.68 | |
| Alexion Pharmaceuticals | 9.5 | $100M | 650k | 152.91 | |
| BioCryst Pharmaceuticals (BCRX) | 7.4 | $78M | 7.6M | 10.17 | |
| Innoviva (INVA) | 7.3 | $77M | 6.4M | 11.95 | |
| Mersana Therapeutics (MRSN) | 6.2 | $65M | 4.0M | 16.18 | |
| Vor Biopharma (VOR) | 2.9 | $31M | 707k | 43.10 | |
| Sarissa Capital Acquisitn W Exp 10/23/202 | 0.5 | $5.0M | 3.3M | 1.50 | |
| Regulus Therapeutics Com New | 0.3 | $2.9M | 1.9M | 1.56 | |
| Mirati Therapeutics | 0.0 | $171k | 1.0k | 171.00 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.0 | $164k | 1.0k | 164.00 | |
| Intercept Pharmaceuticals In | 0.0 | $21k | 950.00 | 22.11 |
